GDF9

Gene Information
 
Gene Symbol
GDF9
 
Aliases
POF14
 
Entrez Gene ID
 
Gene Name
Growth differentiation factor 9
 
Chromosomal Location
5q31.1
 
HGNC ID
 
Summary
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein regulates ovarian function. Reduced expression of this gene may be associated with polycystic ovary syndrome and mutations in this gene may be more common in mothers of dizygotic twins. [provided by RefSeq, Jul 2016]
 
RefSeq DNA
 
RefSeq mRNA
  e!Ensembl
Gene
Transcript  
Protein

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0007179 Biological process Transforming growth factor beta receptor signaling pathway TAS 7760846
GO:0007292 Biological process Female gamete generation TAS 7760846, 8849725
GO:0008284 Biological process Positive regulation of cell proliferation IDA 19366876
GO:0010862 Biological process Positive regulation of pathway-restricted SMAD protein phosphorylation IBA 21873635
GO:0030509 Biological process BMP signaling pathway IBA 21873635
Protein Information
 
Protein Name
Growth/differentiation factor 9
 
Function
Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Promotes cell transition from G0/G1 to S and G2/M phases, through an increase of CCND1 and CCNE1 expression, and RB1 phosphorylation. It regulates STAR expression and cAMP-dependent progesterone release in granulosa and thecal cells. Attenuates the suppressive effects of activin A on STAR expression and progesterone production by increasing the expression of inhibin B. It suppresses FST and FSTL3 production in granulosa-lutein cells.
 
Refseq Proteins
 
UniProt
 
Pfam
Pfam Accession Pfam ID
PF00019 TGF_beta
Pathways
 
KEGG
 
 

Cytokine-cytokine receptor interaction

 

Interactions
 
STRING MINT IntAct
ENSP00000269216 Q92908 Q92908
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Endocrine System Diseases
PCOS
Neoplasms
Ovarian Cancer
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
 
 
 
NIH criteria 
Related 
24 (5 PCOS, 7 PCO, 12 controls) 
The expression of GDF-9 mRNA is delayed and reduced in PCOS and PCO oocytes during their growth and differentiation phase. Because oocyte-derived GDF-9 is crucial for normal folliculogenesis and female fertility, the study suggests that a dysregulation of oocyte GDF-9 expression may contribute to aberrant folliculogenesis in PCOS and PCO women 
BMP15, AMH, AMHR2 
 
 
NIH criteria 
Related 
335 PCOS cases, 198 controls 
Certain GDF9 variants were associated with hirsutism scores and parity in PCOS patients 
BMP15 
 
 
 
Direct 
28 women with PCOS, 26 controls 
The expression of these proteins is reduced and delayed in the early follicular stage in PCOS ovarian tissues, and these differences in expression may be associated with aberrant follicular development in patients with PCOS 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412